2014). Extracorporeal shock wave therapy has been 
suggested as an alternative treatment for refractory 
shoulder pain due to calcific or noncalcific tendinitis 
and may be an alternative to expensive and risky 
surgical interventions (Bannuru et al. 2013). Recent 
studies show the use of ESWT has been suggested 
for the treatment of adhesive capsulitis (Vahdatpour 
et al. 2018). 
The main purpose of the adhesive capsulitis 
treatment is to reduce pain, increase the range of 
joint motion and improve the function of the 
shoulder. Therapeutic effect of ESWT is to help 
revascularization, stimulation, bone reactivation and 
healing of connective tissues, which will lower the 
pain and improve shoulder joint function. 
Shockwave modality uses sound waves of high or 
low energy that impart rapid fluctuations of pressure 
to tissues. The degree of energy imparted to the 
tissues is measured as energy flux density (EFD). 
There are many manufacturers of ESWT devices. 
Shockwave therapy is usually classified as high, 
medium, or low energy, according to the EFD 
administered. Although there is no consensus on the 
threshold values, a commonly used grouping defines 
EFD 0.08 to less than 0.27 mJ/ mm
2
 as low energy, 
0.28 to less than 0.59 mJ/mm
2
 as medium energy, and 
more than 0.60 mJ/mm
2
 as high energy (Speed 2004). 
Several studies have been conducted to observe 
the effects of low dose and high dose rESWT in 
patients with shoulder pathology. Low dose rESWT 
does not reduce pain or improve function compared 
with placebo treatment in patients with chronic 
tendinitis of the rotator cuff (Kolk et al. 2013). 
Systematic review show that high energy fESWT is 
more effective than low energy fESWT for 
improving pain and shoulder function in chronic 
calcific shoulder tendinitis (no similar effects were 
seen in noncalcific tendinitis) and can result in the 
complete resolution of calcifications (Bannuru et al. 
2013). Studies that conducted in adhesive capsulitis 
patients reported more effective responses with 
higher energy and proper session intervals in patients 
with adhesive capsulitis, hematomas as adverse 
event was reported in this study (Hussein et al. 
2015). 
Adverse effects of ESWT were dose dependent, 
patients who received high or medium energy ESWT 
reported more adverse events than those who 
received low energy ESWT. The most commonly 
reported adverse events related to ESWT were 
temporary increase acute pain and local reactions, 
such as swelling, local erythema, petechiae, small 
bruises and hematomas. No serious side effects have 
been reported (Bannuru et al. 2013). 
The aim of this study was to determine the effect 
of low energy rESWT in adhesive capsulitis patient 
related to shoulder pain, shoulder range of motion, 
and function of the shoulder joint. 
2 METHODS 
The study design was an interventional, experimental 
study. A series of single case studies (n=5) was 
undertaken with patients shoulder adhesive capsulitis 
who visited the outpatient clinic of Physical 
Medicine and Rehabilitation Department Hasan 
Sadikin Hospital. The participants received oral and 
written information about the study and were 
informed of the potential risks of treatment. Written 
informed consent was obtained from all subjects 
before the baseline evaluation. Ethical clearence was 
given by the Health Research Ethic Committee 
Hasan Sadikin General Hospital.  
The inclusion criteria were patients 40 - 65 years 
with shoulder pain and restriction in ROM in at least 
three directions, (i.e. flexion, abduction, external 
rotation, and internal rotation) for a duration of at 
least 6 months. Exclusion criteria were history of 
shoulder fracture, shoulder dislocation or 
subluxation, previous surgery on the shoulder, pre-
rupture tendon or tendon rupture in the shoulder 
cancer, glenohumeral or acromioclavicular arthritis, 
presence of severe osteoporosis, inflammatory 
disorders, pulmonary diseases, bleeding disorders, 
pregnancy, any neuromuscular disorders, implanted 
pacemaker and unwillingness to participate in the 
study. 
The rESWT was administered by the same 
experienced trained doctor with the EMS Swiss 
Dolorclast Smart20
®
 (EMS Electro Medical Systems 
Corporation, Dallas, TX, USA). 
Each patient received four applications of 
rESWT, 1 week apart, with 2000 impulses per 
session. The air pressure of the device was set to 2.5 
bars, frequency of 8 Hz, energy flux density (EFD) 
0.11 mJ/mm
2
, and the impulses were applied with a 
15 mm applicator. 
The shock waves were delivered to two separate 
locations per session with the coupling gel. The first 
location was applied 1000 impulses in a posterior-to-
anterior direction on the posterior side of the 
shoulder joint located beneath the lateral border of 
the scapular spine. The second location was applied 
remaining 1000 impulses of the total 2000 impulses 
per session in an anterior-to-posterior direction of the 
anterior shoulder joint, was about one finger breadth 
lateral to the coracoid process (Hussein et al. 2015) 
(Vahdatpour et al. 2018).